TNF and inflammatory bowel disease: Etanercept, differently from other biologics, targets only soluble TNFα and not that bound on the membrane of immune cells, such as macrophages, which was demonstrated to stimulate both T-cell cytokine production and T-cell survival in patients with IBD [61].